Manitoba Life Science News for the week ending March 19, 2010
Summary of this Week’s Newsletter:
Exciting Opportunities
BIO International Convention- May 3rd-May 6th, 2010
Upcoming Events
Centrallia: VIP Information Breakfast- March 26th, 2010
Sixth Annual Regional Bioscience Conference- March 25th & 26th, 2010
Winnipeg Chamber of Commerce Monthly Membership Luncheon with Dr. Frank Plummer- April 22nd, 2010
LSAM Training Events
Simplifying Sales; Sales & Negotiating Training- May 25th- May 27th, 2010
Member News
International Centre for Infectious Diseases Urges Non-Profit Organizations to Develop Pandemic Plans
U of M Researchers Zero in on HIV Vaccine
AstraZeneca Wins First Seroquel Trial, Signs Alzheimer’s Pact
Cangene Announces Second Quarter Financial Results for Fiscal 2010
Life Science in the News
Democrats See Healthcare Bill Passage
Pandemic Flu Vaccine Talks Start
Venture Capital Finally Gets a Break
Drugs Equal to Angioplasty for Relieving Angina: Study
Jail Time for Executives Might Stop Drug Crimes: Ann Woolner
Groundbreaking Trial Could Speed Path to Personalised Medicine
Planes May Fly Mostly on Biofuels With 10 Years
GRE Announces Biorefinery Plans
EXCITING OPPORTUNITIES:
BIO INternational update- May 3rd to May 6th, 2010
The BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry.
The event features keynotes and sessions from key policymakers, scientists, CEOs, and celebrities. Past speakers include President George W. Bush, President Bill Clinton, Michael J. Fox, Sir Elton John, Her Majesty Queen Noor of Jordan, and General Colin Powell, among many others. The Convention also features the BIO Business Forum (One-on-One Partnering), hundreds of sessions covering biotech trends, policy issues and technological innovations, and the world’s largest biotechnology exhibition – the BIO Exhibition .
In 2007, 2008, and 2009 Tradeshow Week (TSW) named the BIO International Convention as one of the Fastest 50, a list of the fastest-growing trade shows. TSW editorial and research staff selected the Fastest 50 based on 50 percent total net square footage growth and 50 percent net growth between 2004 and 2008. In 2009, the BIO International Convention won the award for the fastest-growing Convention owned by a not-for-profit trade association.
Gst Investigational Drug - Bookshelf
ABC Transporters and Multidrug Resistance
A new, oral formulation of the drug is currently tested in MDS patients (81). ... A novel class of GST-P1.1 inhibitor acting through nitric oxide (NO) ...Drug resistance in oncology
These authors also found that the /u. class of rat liver GST isozymes are ... Hexamethylmelamine and pentamethylmelamine are investigational drugs in the ...American journal of hospital pharmacy
AHFS Drug Information Trusted by hospitals.. .extensive enough to serve the needs ... uses of drugs availability of investigational drugs !tf preparations, ...Textbook of therapeutics, drug and disease management
... oxidase MAO-A Phase II Transtormation GST MT NAT ST UGT: See Table 3. 8. ... Not determined Not determined Moclobemide (investigational) Propranolol Not ...Cancer research, a monthly journal of articles and abstracts reporting cancer research
Treatment of K562 erythroblastoid leukemia cells with similar drug .... The GST- Cdc25C200 2,6 fusion protein was generated as described previously (II). ...Everyday Knowledge Directory
EMEA backs orphan status for investigational GST drug ...
EMEA backs orphan status for investigational GST drug. Last Updated: 2005-02-11 15:22:18 ... Orphan drug status would give it 10 years exclusivity in the EU if it ...
Telik Announces Filing of Investigational New Drug ...
Telik Announces Filing of Investigational New Drug Application for TLK199, a Novel Small Molecule Myelostimulant from Business Wire provided by Find Articles at BNET
[Cra gst on investigational drugs] [cra gst on ...
Cra gst on investigational drugs. cra gst on investigational drugs, cra gst on investigational drugs.
Telik Announces Filing of Investigational New Drug ...
Free Online Library: Telik Announces Filing of Investigational New Drug Application for TLK199, a Novel Small Molecule Myelostimulant. by "Business Wire"; Business, ...
Telik, Inc. - TELCYTA™
TELCYTA® (Canfosfamide HCl) is an investigational drug that is a cancer cell-activated ... to GST P1-1, which may limit the ability of GST P1-1 to inactivate other cancer drugs. ...